Results 231 to 240 of about 160,046 (357)

An Integrated Multivariable Artificial Pancreas Control System [PDF]

, 2014
Kamuran Turksoy, Lauretta Quinn, Elizabeth Littlejohn, Ali Çınar   +3 more
openalex   +1 more source

Robustness evaluation of a multivariable fractional order PI controller for time delay processes [PDF]

, 2014
Dulf, Eva H, Ionescu, Clara-Mihaela, Muresan, Cristina I   +2 more
core   +1 more source

Deprescribing drugs with anticholinergic effects in older patients with increased risk of dementia in the multicomponent intervention study AgeWell.de

British Journal of Clinical Pharmacology, EarlyView.
Aim Drugs with anticholinergic effects are often considered as potentially inappropriate medications, especially for older patients, and deprescribing such drugs may improve cognitive function. The aim was to investigate the effectiveness of counselling on drug risks as part of a multimodal intervention to prevent cognitive decline. Methods The AgeWell.
Laura K. Lepenies, Hanna M. Seidling, Alexander Pabst, Melanie Luppa, Juliane Döhring, Martin Williamson, Thomas Frese, Jochen Gensichen, Wolfgang Hoffmann, Hanna Kaduszkiewicz, Hans‐Helmut König, Jochen René Thyrian, Birgitt Wiese, Steffi G. Riedel‐Heller, David Czock   +14 more
wiley   +1 more source

Epidemiologic, histopathological, and prognostic analysis of cancer of unknown primary in an Iranian population. [PDF]

J Res Med Sci
Rayati M, Ahmadi H, Heidarpour M, Najafizade N, Zeinalian M.   +4 more
europepmc   +1 more source

Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres

British Journal of Clinical Pharmacology, EarlyView.
Introduction Bevacizumab, a vascular endothelial growth factor inhibitor, is used off‐label for treatment of severe anaemia related to epistaxis, gastrointestinal bleeding and/or severe hepatic arteriovenous malformations (HAVM) and right‐sided cardiac failure in patients with hereditary haemorrhagic telangiectasia (HHT).
Pernille D. Haahr, Anette D. Kjeldsen, Annette D. Fialla, Anne‐Emmanuelle Fargeton, Alexandre Guilhem, Elisabetta Buscarini, Freya Droege, Guido Manfredi, Hans‐Jurgen Mager, Jean‐Christophe Saurin, Jens Kjeldsen, Josefien Hessels, Marco C. Post, Robert Mandic, Sanne Boerman, Stefan Kasper‐Virchow, Sören Möller, Urban Geisthoff, Sophie Dupuis‐Girod   +18 more
wiley   +1 more source

Event-triggered leader-following tracking control for multivariable multi-agent systems [PDF]

, 2016
Yi Cheng, Valery Ugrinovskii
openalex   +1 more source

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan

British Journal of Clinical Pharmacology, EarlyView.
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang, Chen‐Han Chueh, Chien‐Yu Tseng, Christopher N. Kaufmann, Earl J. Morris, Chiao‐En Wu, Yi‐Wen Tsai   +6 more
wiley   +1 more source

Cognitive-Motor Function During Jump Landings After Anterior Cruciate Ligament Reconstruction. [PDF]

Orthop J Sports Med
Aflatounian F, Becker JN, Hutchison KA, Simon JE, Grooms DR, Monfort SM.   +5 more
europepmc   +1 more source

A NEW PERFORMANCE EVALUATION STRATEGY FOR DECENTRALIZED MULTIVARIABLE PID CONTROL SYSTEMS

, 2007
Gabriele Pannocchia, Claudio Scali
openalex   +1 more source

Association between depression and three key COVID-19-related outcomes: The SHARE study. [PDF]

Hum Vaccin Immunother
Gao Y, Duan C, Miao T, Shen Q, Yu J, Shen S, Chen Y, Shen Y, Zhang K.   +8 more
europepmc   +1 more source